Search results
Results from the WOW.Com Content Network
Maternal serum AFP (MSAFP) varies by orders of magnitude during the course of a normal pregnancy. MSAFP increases rapidly until about 32 weeks gestation, then decreases gradually. After the pregnancy ends it decreases rapidly, with a half-life of about 5 days. Typically, MSAFP is measured in the beginning of the second trimester (14–16 weeks).
174 11576 Ensembl ENSG00000081051 ENSMUSG00000054932 UniProt P02771 P02772 RefSeq (mRNA) NM_001134 NM_001354717 NM_007423 RefSeq (protein) NP_001125 NP_001341646 NP_031449 Location (UCSC) Chr 4: 73.43 – 73.46 Mb Chr 5: 90.64 – 90.66 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Alpha-fetoprotein (AFP, α-fetoprotein ; also sometimes called alpha-1-fetoprotein, alpha ...
Having multiple gestations, such as twins, increases MSAFP because each fetus secretes its own AFP Incorrect estimation of gestational age is the most common cause of abnormal MSAFP levels An example of an algorithm for indications for further testing depending on the outcome of non-genetic blood tests including the triple test.
MSAFP/quad. screen (four simultaneous blood tests) (maternal serum AFP, inhibin A, estriol, and βHCG) – elevations, low numbers or odd patterns correlate with neural tube defect risk and increased risks of trisomy 18 or trisomy 21 [17] Ultrasound either abdominal or transvaginal to assess cervix, placenta, fluid and baby [18]
A multiple of the median (MoM) is a measure of how far an individual test result deviates from the median.MoM is commonly used to report the results of medical screening tests, particularly where the results of the individual tests are highly variable.
Percutaneous umbilical cord blood sampling (PUBS), also called cordocentesis, fetal blood sampling, or umbilical vein sampling is a diagnostic genetic test that examines blood from the fetal umbilical cord to detect fetal abnormalities. [1]
Oligohydramnios is a medical condition in pregnancy characterized by a deficiency of amniotic fluid, the fluid that surrounds the fetus in the abdomen, in the amniotic sac.
Gestational trophoblastic disease (GTD) is a term used for a group of pregnancy-related tumours. [1] These tumours are rare, and they appear when cells in the womb start to proliferate uncontrollably.